| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CRL - Creightons Plc | HOLD | 0 @ USD 99.95 | USD 0 | |
| DVA - DaVita HealthCare Partners Inc | SELL | -50 @ USD 153.36 | USD -7,668 | The ETF sold 50 shares of DVA on 2025-04-10. The shares were previously bought for an average price of USD 155.622. The DaVita HealthCare Partners Inc shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 113 The average price that the ETF previously sold DVA share for is USD 154.009 which is higher than the selling price of USD 153.36 on 2025-04-10. |
| TECH - Bio-Techne Corp | SELL | -170 @ USD 49.26 | USD -8,374 | The ETF sold 170 shares of TECH on 2025-04-10. The shares were previously bought for an average price of USD 66.454. The Bio-Techne Corp shares were sold for -25.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,923 The average price that the ETF previously sold TECH share for is USD 71.8832 which is higher than the selling price of USD 49.26 on 2025-04-10. |
| HSIC - Henry Schein Inc | SELL | -134 @ USD 63.56 | USD -8,517 | The ETF sold 134 shares of HSIC on 2025-04-10. The shares were previously bought for an average price of USD 73.4276. The Henry Schein Inc shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,322 The average price that the ETF previously sold HSIC share for is USD 71.2771 which is higher than the selling price of USD 63.56 on 2025-04-10. |
| MRNA - Moderna Inc | SELL | -360 @ USD 24.5 | USD -8,820 | The ETF sold 360 shares of MRNA on 2025-04-10. The shares were previously bought for an average price of USD 36.3054. The Moderna Inc shares were sold for -32.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,250 The average price that the ETF previously sold MRNA share for is USD 42.6113 which is higher than the selling price of USD 24.5 on 2025-04-10. |
| VTRS - Viatris Inc | SELL | -1,292 @ USD 7.26 | USD -9,380 | The ETF sold 1292 shares of VTRS on 2025-04-10. The shares were previously bought for an average price of USD 10.5477. The Viatris Inc shares were sold for -31.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,248 The average price that the ETF previously sold VTRS share for is USD 12.3945 which is higher than the selling price of USD 7.26 on 2025-04-10. |
| SOLV - Solventum Corp. | SELL | -144 @ USD 65.17 | USD -9,384 | The ETF sold 144 shares of SOLV on 2025-04-10. The shares were previously bought for an average price of USD 74.8416. The Solventum Corp. shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,393 The average price that the ETF previously sold SOLV share for is USD 70.2889 which is higher than the selling price of USD 65.17 on 2025-04-10. |
| INCY - Incyte Corporation | SELL | -174 @ USD 55.17 | USD -9,600 | The ETF sold 174 shares of INCY on 2025-04-10. The shares were previously bought for an average price of USD 69.6912. The Incyte Corporation shares were sold for -20.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,527 The average price that the ETF previously sold INCY share for is USD 73.3194 which is higher than the selling price of USD 55.17 on 2025-04-10. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 178.24 | USD -11,051 | The ETF sold 62 shares of UHS on 2025-04-10. The shares were previously bought for an average price of USD 190.316. The Universal Health Services Inc shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 749 The average price that the ETF previously sold UHS share for is USD 193.147 which is higher than the selling price of USD 178.24 on 2025-04-10. |
| RVTY - Revvity Inc. | SELL | -134 @ USD 93.02 | USD -12,465 | The ETF sold 134 shares of RVTY on 2025-04-10. The shares were previously bought for an average price of USD 113.419. The Revvity Inc. shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,733 The average price that the ETF previously sold RVTY share for is USD 114.949 which is higher than the selling price of USD 93.02 on 2025-04-10. |
| ALGN - Align Technology Inc | SELL | -78 @ USD 160.14 | USD -12,491 | The ETF sold 78 shares of ALGN on 2025-04-10. The shares were previously bought for an average price of USD 188.921. The Align Technology Inc shares were sold for -15.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,245 The average price that the ETF previously sold ALGN share for is USD 217.544 which is higher than the selling price of USD 160.14 on 2025-04-10. |
| HOLX - Hologic Inc | SELL | -242 @ USD 57.16 | USD -13,833 | The ETF sold 242 shares of HOLX on 2025-04-10. The shares were previously bought for an average price of USD 67.6959. The Hologic Inc shares were sold for -15.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,550 The average price that the ETF previously sold HOLX share for is USD 72.9657 which is higher than the selling price of USD 57.16 on 2025-04-10. |
| BAX - Baxter International Inc | SELL | -548 @ USD 28.14 | USD -15,421 | The ETF sold 548 shares of BAX on 2025-04-10. The shares were previously bought for an average price of USD 33.5986. The Baxter International Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,991 The average price that the ETF previously sold BAX share for is USD 32.5761 which is higher than the selling price of USD 28.14 on 2025-04-10. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 203.75 | USD -15,893 | The ETF sold 78 shares of WST on 2025-04-10. The shares were previously bought for an average price of USD 260.276. The West Pharmaceutical Services Inc shares were sold for -21.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,409 The average price that the ETF previously sold WST share for is USD 309.783 which is higher than the selling price of USD 203.75 on 2025-04-10. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -220 @ USD 75.37 | USD -16,581 | The ETF sold 220 shares of COO on 2025-04-10. The shares were previously bought for an average price of USD 89.6769. The The Cooper Companies, Inc. Common Stock shares were sold for -16.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,148 The average price that the ETF previously sold COO share for is USD 97.012 which is higher than the selling price of USD 75.37 on 2025-04-10. |
| BIIB - Biogen Inc | SELL | -158 @ USD 113.38 | USD -17,914 | The ETF sold 158 shares of BIIB on 2025-04-10. The shares were previously bought for an average price of USD 148.189. The Biogen Inc shares were sold for -23.5% lower than average price of previous purchases. This resulted in an overall loss of USD 5,500 The average price that the ETF previously sold BIIB share for is USD 159.935 which is higher than the selling price of USD 113.38 on 2025-04-10. |
| PODD - Insulet Corporation | SELL | -76 @ USD 251.47 | USD -19,112 | The ETF sold 76 shares of PODD on 2025-04-10. The shares were previously bought for an average price of USD 269.112. The Insulet Corporation shares were sold for -6.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,341 The average price that the ETF previously sold PODD share for is USD 260.961 which is higher than the selling price of USD 251.47 on 2025-04-10. |
| LH - Laboratory Corporation of America Holdings | SELL | -90 @ USD 218.61 | USD -19,675 | The ETF sold 90 shares of LH on 2025-04-10. The shares were previously bought for an average price of USD 241.619. The Laboratory Corporation of America Holdings shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,071 The average price that the ETF previously sold LH share for is USD 236.036 which is higher than the selling price of USD 218.61 on 2025-04-10. |
| DGX - Quest Diagnostics Incorporated | SELL | -122 @ USD 163.85 | USD -19,990 | The ETF sold 122 shares of DGX on 2025-04-10. The shares were previously bought for an average price of USD 166.319. The Quest Diagnostics Incorporated shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 301 The average price that the ETF previously sold DGX share for is USD 158.761 so the ETF has sold 122 shares on 2025-04-10 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -64 @ USD 314.66 | USD -20,138 | The ETF sold 64 shares of WAT on 2025-04-10. The shares were previously bought for an average price of USD 371.732. The Waters Corporation shares were sold for -15.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,653 The average price that the ETF previously sold WAT share for is USD 374.314 which is higher than the selling price of USD 314.66 on 2025-04-10. |
| WAT - MULETFWATIMETFP | SELL | -64 @ USD 314.66 | USD -20,138 | The ETF sold 64 shares of WAT on 2025-04-10. The shares were previously bought for an average price of USD 371.732. The MULETFWATIMETFP shares were sold for -15.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,653 The average price that the ETF previously sold WAT share for is USD 374.314 which is higher than the selling price of USD 314.66 on 2025-04-10. |
| MOH - MOH | SELL | -60 @ USD 342.68 | USD -20,561 | The ETF sold 60 shares of MOH on 2025-04-10. The shares were previously bought for an average price of USD 308.09. The MOH shares were sold for 11.2% higher than average price of previous purchases. This sale made a profit of USD 2,075 The average price that the ETF previously sold MOH share for is USD 305.782 so the ETF has sold 60 shares on 2025-04-10 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 342.68 | USD -20,561 | The ETF sold 60 shares of MOH on 2025-04-10. The shares were previously bought for an average price of USD 308.09. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 11.2% higher than average price of previous purchases. This sale made a profit of USD 2,075 The average price that the ETF previously sold MOH share for is USD 305.782 so the ETF has sold 60 shares on 2025-04-10 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -212 @ USD 102.26 | USD -21,679 | The ETF sold 212 shares of ZBH on 2025-04-10. The shares were previously bought for an average price of USD 107.914. The Zimmer Biomet Holdings Inc shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,199 The average price that the ETF previously sold ZBH share for is USD 107.802 which is higher than the selling price of USD 102.26 on 2025-04-10. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 997.69 | USD -21,949 | The ETF sold 22 shares of MTD on 2025-04-10. The shares were previously bought for an average price of USD 1254.84. The Mettler-Toledo International Inc shares were sold for -20.5% lower than average price of previous purchases. This resulted in an overall loss of USD 5,657 The average price that the ETF previously sold MTD share for is USD 1247.7 which is higher than the selling price of USD 997.69 on 2025-04-10. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 997.69 | USD -21,949 | The ETF sold 22 shares of MTD on 2025-04-10. The shares were previously bought for an average price of USD 1254.84. The AMUNDI EUR GOV 710 shares were sold for -20.5% lower than average price of previous purchases. This resulted in an overall loss of USD 5,657 The average price that the ETF previously sold MTD share for is USD 1247.7 which is higher than the selling price of USD 997.69 on 2025-04-10. |
| STE - STERIS plc | SELL | -108 @ USD 217.12 | USD -23,449 | The ETF sold 108 shares of STE on 2025-04-10. The shares were previously bought for an average price of USD 221.85. The STERIS plc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 511 The average price that the ETF previously sold STE share for is USD 214.535 so the ETF has sold 108 shares on 2025-04-10 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -182 @ USD 143.22 | USD -26,066 | The ETF sold 182 shares of IQV on 2025-04-10. The shares were previously bought for an average price of USD 195.932. The IQVIA Holdings Inc shares were sold for -26.9% lower than average price of previous purchases. This resulted in an overall loss of USD 9,594 The average price that the ETF previously sold IQV share for is USD 200.035 which is higher than the selling price of USD 143.22 on 2025-04-10. |
| DXCM - DexCom Inc | SELL | -424 @ USD 67.3 | USD -28,535 | The ETF sold 424 shares of DXCM on 2025-04-10. The shares were previously bought for an average price of USD 78.1718. The DexCom Inc shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,610 The average price that the ETF previously sold DXCM share for is USD 75.429 which is higher than the selling price of USD 67.3 on 2025-04-10. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -492 @ USD 62.28 | USD -30,642 | The ETF sold 492 shares of GEHC on 2025-04-10. The shares were previously bought for an average price of USD 86.402. The GE HealthCare Technologies Inc. shares were sold for -27.9% lower than average price of previous purchases. This resulted in an overall loss of USD 11,868 The average price that the ETF previously sold GEHC share for is USD 81.9634 which is higher than the selling price of USD 62.28 on 2025-04-10. |
| A - Agilent Technologies Inc | SELL | -310 @ USD 99.95 | USD -30,985 | The ETF sold 310 shares of A on 2025-04-10. The shares were previously bought for an average price of USD 130.969. The Agilent Technologies Inc shares were sold for -23.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,616 The average price that the ETF previously sold A share for is USD 133.864 which is higher than the selling price of USD 99.95 on 2025-04-10. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 381.83 | USD -33,601 | The ETF sold 88 shares of IDXX on 2025-04-10. The shares were previously bought for an average price of USD 438.569. The IDEXX Laboratories Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,993 The average price that the ETF previously sold IDXX share for is USD 425.382 which is higher than the selling price of USD 381.83 on 2025-04-10. |
| RMD - ResMed Inc | SELL | -160 @ USD 210.55 | USD -33,688 | The ETF sold 160 shares of RMD on 2025-04-10. The shares were previously bought for an average price of USD 234.489. The ResMed Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,830 The average price that the ETF previously sold RMD share for is USD 240.301 which is higher than the selling price of USD 210.55 on 2025-04-10. |
| CNC - Concurrent Technologies Plc | SELL | -542 @ USD 62.39 | USD -33,815 | The ETF sold 542 shares of CNC on 2025-04-10. The shares were previously bought for an average price of USD 60.022. The Concurrent Technologies Plc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 1,283 The average price that the ETF previously sold CNC share for is USD 60.0185 so the ETF has sold 542 shares on 2025-04-10 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -264 @ USD 128.88 | USD -34,024 | The ETF sold 264 shares of CAH on 2025-04-10. The shares were previously bought for an average price of USD 127.147. The Cardinal Health Inc shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 458 The average price that the ETF previously sold CAH share for is USD 121.267 so the ETF has sold 264 shares on 2025-04-10 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -130 @ USD 290.25 | USD -37,733 | The ETF sold 130 shares of HUM on 2025-04-10. The shares were previously bought for an average price of USD 271.518. The Hummingbird Resources PLC shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 2,435 The average price that the ETF previously sold HUM share for is USD 278.486 so the ETF has sold 130 shares on 2025-04-10 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -130 @ USD 290.25 | USD -37,733 | The ETF sold 130 shares of HUM on 2025-04-10. The shares were previously bought for an average price of USD 271.518. The Humana Inc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 2,435 The average price that the ETF previously sold HUM share for is USD 278.486 so the ETF has sold 130 shares on 2025-04-10 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -640 @ USD 68.26 | USD -43,686 | The ETF sold 640 shares of EW on 2025-04-10. The shares were previously bought for an average price of USD 71.1015. The Edwards Lifesciences Corp shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,819 The average price that the ETF previously sold EW share for is USD 70.1556 which is higher than the selling price of USD 68.26 on 2025-04-10. |
| COR - Cencora Inc. | SELL | -188 @ USD 279.15 | USD -52,480 | The ETF sold 188 shares of COR on 2025-04-10. The shares were previously bought for an average price of USD 251.456. The Cencora Inc. shares were sold for 11.0% higher than average price of previous purchases. This sale made a profit of USD 5,206 The average price that the ETF previously sold COR share for is USD 243.987 so the ETF has sold 188 shares on 2025-04-10 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -312 @ USD 199.12 | USD -62,125 | The ETF sold 312 shares of BDX on 2025-04-10. The shares were previously bought for an average price of USD 230.837. The Becton Dickinson and Company shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,896 The average price that the ETF previously sold BDX share for is USD 226.118 which is higher than the selling price of USD 199.12 on 2025-04-10. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -114 @ USD 546.39 | USD -62,288 | The ETF sold 114 shares of REGN on 2025-04-10. The shares were previously bought for an average price of USD 716.103. The Regeneron Pharmaceuticals Inc shares were sold for -23.7% lower than average price of previous purchases. This resulted in an overall loss of USD 19,347 The average price that the ETF previously sold REGN share for is USD 759.513 which is higher than the selling price of USD 546.39 on 2025-04-10. |
| HCA - HCA Holdings Inc | SELL | -194 @ USD 334.99 | USD -64,988 | The ETF sold 194 shares of HCA on 2025-04-10. The shares were previously bought for an average price of USD 337.144. The HCA Holdings Inc shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 418 The average price that the ETF previously sold HCA share for is USD 325.558 so the ETF has sold 194 shares on 2025-04-10 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -486 @ USD 147 | USD -71,442 | The ETF sold 486 shares of ZTS on 2025-04-10. The shares were previously bought for an average price of USD 168.375. The Zoetis Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 10,388 The average price that the ETF previously sold ZTS share for is USD 172.633 which is higher than the selling price of USD 147 on 2025-04-10. |
| MCK - McKesson Corporation | SELL | -136 @ USD 679.33 | USD -92,389 | The ETF sold 136 shares of MCK on 2025-04-10. The shares were previously bought for an average price of USD 613.909. The McKesson Corporation shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 8,897 The average price that the ETF previously sold MCK share for is USD 597.528 so the ETF has sold 136 shares on 2025-04-10 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -1,368 @ USD 68.97 | USD -94,351 | The ETF sold 1368 shares of CVS on 2025-04-10. The shares were previously bought for an average price of USD 62.6022. The CVS Health Corp shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of USD 8,711 The average price that the ETF previously sold CVS share for is USD 54.8212 so the ETF has sold 1368 shares on 2025-04-10 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -298 @ USD 327.27 | USD -97,526 | The ETF sold 298 shares of CI on 2025-04-10. The shares were previously bought for an average price of USD 315.276. The Cigna Corp shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 3,574 The average price that the ETF previously sold CI share for is USD 312.448 so the ETF has sold 298 shares on 2025-04-10 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -252 @ USD 436.37 | USD -109,965 | The ETF sold 252 shares of ELV on 2025-04-10. The shares were previously bought for an average price of USD 410.613. The Elevance Health Inc shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 6,491 The average price that the ETF previously sold ELV share for is USD 401.67 so the ETF has sold 252 shares on 2025-04-10 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -252 @ USD 436.37 | USD -109,965 | The ETF sold 252 shares of ELV on 2025-04-10. The shares were previously bought for an average price of USD 410.613. The Elevance Health Inc shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 6,491 The average price that the ETF previously sold ELV share for is USD 401.67 so the ETF has sold 252 shares on 2025-04-10 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,204 @ USD 50.46 | USD -111,214 | The ETF sold 2204 shares of BMY on 2025-04-10. The shares were previously bought for an average price of USD 58.1671. The Bloomsbury Publishing Plc shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 16,986 The average price that the ETF previously sold BMY share for is USD 57.0612 which is higher than the selling price of USD 50.46 on 2025-04-10. |
| MDT - Medtronic PLC | SELL | -1,394 @ USD 82.54 | USD -115,061 | The ETF sold 1394 shares of MDT on 2025-04-10. The shares were previously bought for an average price of USD 89.2052. The Medtronic PLC shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,291 The average price that the ETF previously sold MDT share for is USD 85.4618 which is higher than the selling price of USD 82.54 on 2025-04-10. |
| DHR - Danaher Corporation | SELL | -696 @ USD 180.76 | USD -125,809 | The ETF sold 696 shares of DHR on 2025-04-10. The shares were previously bought for an average price of USD 218.674. The Danaher Corporation shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 26,388 The average price that the ETF previously sold DHR share for is USD 233.957 which is higher than the selling price of USD 180.76 on 2025-04-10. |
| DHR - Danaher Corporation | SELL | -696 @ USD 180.76 | USD -125,809 | The ETF sold 696 shares of DHR on 2025-04-10. The shares were previously bought for an average price of USD 218.674. The Danaher Corporation shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 26,388 The average price that the ETF previously sold DHR share for is USD 233.957 which is higher than the selling price of USD 180.76 on 2025-04-10. |
| SYK - Stryker Corporation | SELL | -374 @ USD 348.39 | USD -130,298 | The ETF sold 374 shares of SYK on 2025-04-10. The shares were previously bought for an average price of USD 380.491. The Stryker Corporation shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 12,006 The average price that the ETF previously sold SYK share for is USD 374.995 which is higher than the selling price of USD 348.39 on 2025-04-10. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -278 @ USD 475.49 | USD -132,186 | The ETF sold 278 shares of VRTX on 2025-04-10. The shares were previously bought for an average price of USD 479.413. The Vertex Pharmaceuticals Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,091 The average price that the ETF previously sold VRTX share for is USD 464.508 so the ETF has sold 278 shares on 2025-04-10 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,150 @ USD 21.59 | USD -132,779 | The ETF sold 6150 shares of PFE on 2025-04-10. The shares were previously bought for an average price of USD 26.0705. The Pfizer Inc shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 27,555 The average price that the ETF previously sold PFE share for is USD 26.158 which is higher than the selling price of USD 21.59 on 2025-04-10. |
| GILD - Guild Esports Plc | SELL | -1,352 @ USD 101.4 | USD -137,093 | The ETF sold 1352 shares of GILD on 2025-04-10. The shares were previously bought for an average price of USD 102.997. The Guild Esports Plc shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,159 The average price that the ETF previously sold GILD share for is USD 94.0078 so the ETF has sold 1352 shares on 2025-04-10 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -1,602 @ USD 92.64 | USD -148,409 | The ETF sold 1602 shares of BSX on 2025-04-10. The shares were previously bought for an average price of USD 98.4145. The Boston Scientific Corporation shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 9,251 The average price that the ETF previously sold BSX share for is USD 89.9015 so the ETF has sold 1602 shares on 2025-04-10 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,602 @ USD 92.64 | USD -148,409 | The ETF sold 1602 shares of BSX on 2025-04-10. The shares were previously bought for an average price of USD 98.4145. The MULSTRXSSXIMETFP shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 9,251 The average price that the ETF previously sold BSX share for is USD 89.9015 so the ETF has sold 1602 shares on 2025-04-10 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -584 @ USD 281.41 | USD -164,343 | The ETF sold 584 shares of AMGN on 2025-04-10. The shares were previously bought for an average price of USD 305.685. The Amgen Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 14,177 The average price that the ETF previously sold AMGN share for is USD 290.13 which is higher than the selling price of USD 281.41 on 2025-04-10. |
| TMO - Time Out Group plc | SELL | -416 @ USD 427.44 | USD -177,815 | The ETF sold 416 shares of TMO on 2025-04-10. The shares were previously bought for an average price of USD 530.968. The Time Out Group plc shares were sold for -19.5% lower than average price of previous purchases. This resulted in an overall loss of USD 43,068 The average price that the ETF previously sold TMO share for is USD 528.438 which is higher than the selling price of USD 427.44 on 2025-04-10. |
| ISRG - Intuitive Surgical Inc | SELL | -388 @ USD 489.52 | USD -189,934 | The ETF sold 388 shares of ISRG on 2025-04-10. The shares were previously bought for an average price of USD 543.288. The Intuitive Surgical Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 20,862 The average price that the ETF previously sold ISRG share for is USD 530.619 which is higher than the selling price of USD 489.52 on 2025-04-10. |
| MRK - Marks Electrical Group PLC | SELL | -2,750 @ USD 77.55 | USD -213,263 | The ETF sold 2750 shares of MRK on 2025-04-10. The shares were previously bought for an average price of USD 93.0405. The Marks Electrical Group PLC shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 42,599 The average price that the ETF previously sold MRK share for is USD 99.9439 which is higher than the selling price of USD 77.55 on 2025-04-10. |
| MRK - Merck & Company Inc | SELL | -2,750 @ USD 77.55 | USD -213,263 | The ETF sold 2750 shares of MRK on 2025-04-10. The shares were previously bought for an average price of USD 93.0405. The Merck & Company Inc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 42,599 The average price that the ETF previously sold MRK share for is USD 99.9439 which is higher than the selling price of USD 77.55 on 2025-04-10. |
| ABT - Abbott Laboratories | SELL | -1,882 @ USD 124.5 | USD -234,309 | The ETF sold 1882 shares of ABT on 2025-04-10. The shares were previously bought for an average price of USD 126.661. The Abbott Laboratories shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,067 The average price that the ETF previously sold ABT share for is USD 117.097 so the ETF has sold 1882 shares on 2025-04-10 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -1,918 @ USD 174.2 | USD -334,116 | The ETF sold 1918 shares of ABBV on 2025-04-10. The shares were previously bought for an average price of USD 194.397. The AbbVie Inc shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 38,738 The average price that the ETF previously sold ABBV share for is USD 185.474 which is higher than the selling price of USD 174.2 on 2025-04-10. |
| JNJ - Johnson & Johnson | SELL | -2,616 @ USD 148.69 | USD -388,973 | The ETF sold 2616 shares of JNJ on 2025-04-10. The shares were previously bought for an average price of USD 158.317. The Johnson & Johnson shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 25,184 The average price that the ETF previously sold JNJ share for is USD 152.748 which is higher than the selling price of USD 148.69 on 2025-04-10. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,000 @ USD 594.4 | USD -594,400 | The ETF sold 1000 shares of UNH on 2025-04-10. The shares were previously bought for an average price of USD 536.071. The UnitedHealth Group Incorporated shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of USD 58,329 The average price that the ETF previously sold UNH share for is USD 565.358 so the ETF has sold 1000 shares on 2025-04-10 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -856 @ USD 720.91 | USD -617,099 | The ETF sold 856 shares of LLY on 2025-04-10. The shares were previously bought for an average price of USD 842.018. The Eli Lilly and Company shares were sold for -14.4% lower than average price of previous purchases. This resulted in an overall loss of USD 103,668 The average price that the ETF previously sold LLY share for is USD 797.717 which is higher than the selling price of USD 720.91 on 2025-04-10. |